Inhibition of T cell/B cell interaction by B-CLL cells

Leukemia

Volumn 13, Issue 1, 1999, Pages 98-104

  Kneitz, C ^b   Goller, M ^b   Wilhelm, M ^b   Mehringer, C ^b   Wohlleben, G ^b   Schimpl, A ^b   Tony, H P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NONE

Author keywords

B cell T cell interaction; B CLL; CD40; CD40 ligand

Indexed keywords

CD23 ANTIGEN; CD4 ANTIGEN; GLYCOPROTEIN GP 39;

ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CANCER IMMUNOLOGY; CELL INTERACTION; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032919212     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401235     Document Type: Article

References (41)

1. Dighiero G, Travede P, Chevret S, Fenaux P, Chastang C, Binet J-L and the French Cooperative Group on CLL. B-cell chronic leukemia: present status and future directions. Blood 1991; 78: 1901-1914.
2. Chapel H, Buch C. Mechanisms of infection in chronic lymphocytic leukemia. Semin Hematol 1987; 24: 291-296.
3. De Rossi G, Granati L, Girelli G, Gandolto G, Arista MC, Martelli M, Conti L, Marini R, La Tagliata R, Leone R, Mandelli F. Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL). Nouv Rev Fr Hematol 1988; 30: 403-406.
4. Hansen MM. Chronic lymphocytic leukemia: clinical studies based on 189 cases followed for a long time. Stand J Haematol 1973; 18: 1-286.
5. Hamblin TJ, Oscier DJ, Young BJ. Autoimmunity in chronic lymphocytic leukemia. J Clin Pathol 1986; 39: 713-716.
6. Kobayashi R, Picchio G, Kirven M, Meisenholder G, Baird S, Carson DA, Mosier DE, Kipps TJ. Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency. Leukemia Res 1992; 16: 1013-1023.
7. Dighiero G. An attempt to explain disordered immunity and hypogammaglobulinemia in CLL. Nouv Rev Fr Hematol 1988; 30: 283-288.
8. + cell clones. J Immunol 1990: 144: 2550-2557.
9. Duan X, Nerl C, Janssen O, Kabelitz D. B cell maturation in chronic lymphocytic leukemia. IV. T cell-dependent activation of leukemic cells by staphylococcal enterotoxin 'superantigens'. Immunol 1992; 75: 420-426.
10. Gobbi M, Caligaris-Cappio F, Janossy G. Normal equivalent of B cell malignancies: analysis with monoclonal antibodies. Br J Haematol 1983; 54: 393-403.
11. Tony HP, Lehrnbecher T, Merz H, Sebald W, Wilhelm M. Regulation of IL-4 responsiveness in lymphoma B cells. Leukemia Res 1991; 15: 911-919.
12. Tony HP, Brückner A, Wilhelm M. Differential signal requirement for upregulation of HLA-class-II molecules in lymphoma B cells. Hematol Pathol 1993; 7: 79-90.
13. Hermann P, Van-Kooten C, Gaillard C, Banchereau J, Blanchard D. CD40 ligand positive CD8 T cell clones allow B cell growth and differentiation. Eur J Immunol 1995; 25: 2972-2977.
14. Blanchard D, Gaillard C, Hermann P, Banchereau J. Role of CD40 antigen and interleukin-2 in T cell dependent human B lymphocyte growth. Eur J Immunol 1994; 24: 330-335.
15. Decker T, Flohr T, Trautmann P, Aman MJ, Holter W, Majdic O, Huber C, Peschel C. Role of accessory cells in cytokine production by T cells in chronic B cell lymphocytic leukemia. Blood 1995; 86: 1115-1123.
16. Allison JP. CD28-B7 interactions in T cell activation. Curr Opin Immunol 1994; 6: 414-419.
17. Durie FH, Foy TM, Masters SR, Lamann JD, Noelle, RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15: 406-411.
18. Banchereau J, Bazan F, Blanchard D, Brière F, Galizzi JP, van Kooten, C, Liu JY, Rousset F, Saeland S. The CD40 antigen and its ligand. Ann Rev Immunol 1994; 12: 881-922.
19. Banchereau J, Rousset F. Growing human B lymphocytes in the CD40 system. Nature 1991; 353: 678-679.
20. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B cell activation. Immunol Today 1992; 13: 431-433.
21. Wohlleben G, Gray D, Schimpl A. In vitro immunization of naive mouse B cells: establishment of IgM secreting hybridomas specific for soluble protein or hapten from B cells cultured on CD40 ligand transfected mouse fibroblasts. Int Immunol 1996; 8: 343-349.
22. Caligaris-Cappio F, Janossy G. Surface markers in chronic lymphocytic leukemias of B cell type. Semin Hematol 1985; 22: 1-12.
23. Kaplan ME, Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Meth 1974; 5: 131-135.
24. Kikutani H, Suemura M, Owaki H, Nakamura H, Sato R, Yamsaki K, Barsumian EL, Hardy RR, Kishimoto T. Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J Exp Med 1986; 164: 1455-1469.
25. Bonnefoy JY, Leconaet-Henchoz S, Aubry JP, Gauchat JF, Graber P. CD23 and B cell activation. Curr Opin Immunol 1995; 7: 355-359.
26. Fournier S, Tran ID, Suter U, Biron G, Delespess G, Sarfati M. The in vivo expression of type b CD23 mRNA in B chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts. Leukemia Res 1991; 15: 609-618.
27. Schuh K, Avots A, Tony HP, Serfling E, Kneitz C. Nuclear NF-ATp is a hallmark of unstimulated B cells from B-CLL patients. Leuk Lymphoma 1996; 23: 583-592.
28. Sarfati M. Interleukin 4 and the two isoforms of CD23 antigen: their possible contribution to the physiopathology of chronic lymphocytic disease. Nouv Rev Fr Hematol 1993; 35: 109-113.
29. Kipps TJ, Carson DA. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune disease. Blood 1993; 81: 2475-2487.
30. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 367: 425-428.
31. Nishioka Y, Lipsky PE. The role of CD40-CD40 ligand interaction in human T cell/B-cell collaboration. J Immunol 1994; 153: 1027-1036.
32. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, MacDuff KM, Sato TA, Maliszewski CR, Fanslow WC. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992; 176: 1543-1550.
33. Korthauer U, Graf D, Mages HW, Briere E, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM (see comments). Nature 1993; 361: 539-541.
34. Fu SM, Chiorazzi N, Kunkel HG. Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev 1979; 48: 23-44.
35. Van Kooten C, Gaillard C, Galizzi J-P, Hermann P, Fossiez F, Banchereau J, Blanchard D. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 1994; 24: 787-792.
36. MacLennan ICM. Germinal center. Annu Rev Immunol 1994; 12: 17-39.
37. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Sprigs MK, Fanslow WC, MacLennan ICM, Gregory CD, Gordon J. Suppression of apoptosis in normal and neoplastic human B lymphocytes. Eur J Immunol 1993; 23: 2368-2371.
38. Yellin MJ, Sippel K, Inghirami G, Covey LR, Lee JJ, Sinning J, Clark EA, Chess L, Lederman S. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. J Immunol 1994; 152: 598-608.
39. Cantwell M, Hua T, Pappas J, Kipps TJ. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nature Med 1997; 3, 984-989.
40. Biondi A, Rossi V, Bassan R, Barbui T, Bettoni S, Sironi M, Mantovani A, Rambaldi A. Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 1989; 73: 1279-1284.
41. Foa R, Massaia M, Cardona S, Tos AG, Blanchi A, Attisano C, Guarini A, di Celle PF, Fierro MT. Production of tumor necrosis factor alpha by B-cell chronic lymphocytic leukemia cells: a possible role of TNF in the progression of the disease. Blood 1990; 76: 393-400.